Guide
Multilingual Labeling: Considerations for Efficient, Cost Effective and Compliance Labeling
Accurate and compliant labeling of an investigational medicinal product (IMP) is an important and integral part of clinical trial operations. A misstep in labeling can lead to significant delays, affecting the entire study’s timeline and potentially incurring costs ranging from $100,000 to $700,000 in hard expenses. In worst-case scenarios, incorrect labeling might necessitate a complete product reproduction. Learn more about the strategies and solutions leading sponsors are leveraging to ensure excellence and efficiency in IMP labeling for clinical trials.
